TED Talks Daily What happens after we develop a COVID-19 vaccine? | Johanna Benesty
Nov 18, 2020
In this insightful talk, global health strategist Johanna Benesty dives into the complexities surrounding COVID-19 vaccine distribution. She highlights barriers to equitable access, emphasizing the necessity of universal availability for all communities. Johanna shares innovative strategies for fair vaccine rollout amid supply challenges. She also discusses the importance of integrating cost management in research to ensure scalability and accessibility, paving the way for a more effective global health response.
AI Snips
Chapters
Transcript
Episode notes
COVID-19 Tool Arsenal
- COVID-19 requires a range of tools, not just a vaccine.
- Therapeutics and diagnostics are crucial for prevention, identification, and treatment.
Vaccine Access Challenges
- Vaccine access will be a major challenge, affecting everyone.
- COVID-19's speed and scale expose us all to similar access limitations.
Limited Vaccine Supply
- Vaccine supply will be limited initially, creating allocation dilemmas.
- By the end of 2021, only enough doses for 1-2 billion people are expected.